Search research articles
Contact Us
Filters
Showing results (31-40 of 194) with videos related to
Page
of 20
Sort By:
Expert Opinion on Pharmacotherapy
|
August 2, 2008
A new lipoglycopeptide: telavancin
Esteban C Nannini, Martin E Stryjewski
Journal of Clinical Microbiology
|
October 23, 2009
Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial
In-Gyu Bae, Giang T Tonthat, Martin E Stryjewski, et al.
BMC Infectious Diseases
|
June 3, 2014
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
Martin E Stryjewski, Arnold Lentnek, William O'Riordan, et al.
International Journal of Antimicrobial Agents
|
July 30, 2013
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia
Martin E Stryjewski, Steven L Barriere, Ethan Rubinstein, et al.
The American Journal of Medicine
|
March 5, 2005
Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia
Fadi El-Ahdab, Daniel Kelly Benjamin, Andrew Wang, et al.
International Journal of Antimicrobial Agents
|
September 9, 2008
Risk of intravascular cardiac device infections in patients with bacteraemia: impact on device removal
G Ralph Corey, Tahaniyat Lalani
Infection and Drug Resistance
|
May 31, 2014
Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
Ethan Rubinstein, Martin E Stryjewski, Steven L Barriere
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 9, 2009
A balancing act: microbe versus muscle
Sara E Cosgrove, G Ralph Corey
Expert Opinion on Investigational Drugs
|
February 14, 2012
Tedizolid (TR-701): a new oxazolidinone with enhanced potency
Zeina A Kanafani, G Ralph Corey
Future Microbiology
|
February 12, 2009
Ceftaroline: a cephalosporin with expanded Gram-positive activity
Zeina A Kanafani, G Ralph Corey
Page
of 20
Search research articles
Search
Showing results (31-40 of 194) with videos related to
Sort By:
Page
of 20
Expert Opinion on Pharmacotherapy
|
August 2, 2008
A new lipoglycopeptide: telavancin
Esteban C Nannini, Martin E Stryjewski
Journal of Clinical Microbiology
|
October 23, 2009
Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial
In-Gyu Bae, Giang T Tonthat, Martin E Stryjewski, et al.
BMC Infectious Diseases
|
June 3, 2014
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
Martin E Stryjewski, Arnold Lentnek, William O'Riordan, et al.
International Journal of Antimicrobial Agents
|
July 30, 2013
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia
Martin E Stryjewski, Steven L Barriere, Ethan Rubinstein, et al.
The American Journal of Medicine
|
March 5, 2005
Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia
Fadi El-Ahdab, Daniel Kelly Benjamin, Andrew Wang, et al.
International Journal of Antimicrobial Agents
|
September 9, 2008
Risk of intravascular cardiac device infections in patients with bacteraemia: impact on device removal
G Ralph Corey, Tahaniyat Lalani
Infection and Drug Resistance
|
May 31, 2014
Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
Ethan Rubinstein, Martin E Stryjewski, Steven L Barriere
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 9, 2009
A balancing act: microbe versus muscle
Sara E Cosgrove, G Ralph Corey
Expert Opinion on Investigational Drugs
|
February 14, 2012
Tedizolid (TR-701): a new oxazolidinone with enhanced potency
Zeina A Kanafani, G Ralph Corey
Future Microbiology
|
February 12, 2009
Ceftaroline: a cephalosporin with expanded Gram-positive activity
Zeina A Kanafani, G Ralph Corey
Page
of 20